CM opens Suzen Medicare’s ₹180 crore IV fluid unit, bats for more private investments

Chief Minister A. Revanth Reddy underscored the significance of encouraging private investments as they help generate more job opportunities.

The Chief Minister, who inaugurated Suzen Medicare’s fluid manufacturing plant in Maheshwaram on Friday, also sought to highlight how continuous hard work over the last three decades had yielded desirable results and was behind Hyderabad competing with global cities now.

Set up at an investment of ₹180 crore, the Suzen Medicare will produce IV fluids and antibiotics. The facility is ready to get into production. The 1.60 lakh sq ft unit has been set up on four acres in E-City and the company has entered into a technology tie up with Rommelag of Germany, a well known packaging services provider for injectables, sources in Suzen said.

Noting that the setting up of Suzen Medicare unit for manufacturing IV fluids using German technology was commendable, Mr. Revanth Reddy said that the decision of the company was driven by his government’s Telangana Rising 2047 vision. As part of the Vision, the government has committed to make Telangana a $1 trillion economy by 2034 and $3 trillion by 2047.

Both the Core Urban Region Economy (CURE) or the hub for high value services, technology, innovation and urban economic engines as well as the Peri Urban Region Economy (PURE), which essentially will be the zone driving large scale manufacturing, industrial growth and production infrastructure, will play a vital role to spur a strong economic activity in the State.

With Hyderabad already competing with the world’s greatest cities, Telangana is poised to compete with Germany, Japan, South Korea and New York. “As part of this, we are encouraging industries started by young entrepreneurs,” the Chief Minister said.

He said 40% of the bulk drugs produced in the country are manufactured in Telangana. “We are excelling in the pharma sector and the entire world is looking at Hyderabad. Those who studied here have become CEOs of global companies. This is a matter of great pride for us,” he declared.

According to Suzen Medicare website, in addition to catering to IV fluid demand in domestic and global markets, the company is keen on catering to leading pharmaceutical companies as a contract manufacturer.